Provided by Tiger Trade Technology Pte. Ltd.

VanEck Healthcare TruSector ETF

30.48
+0.01520.05%
Post-market: 30.46-0.0195-0.06%16:10 EDT
Volume:523
Turnover:15.96K
Market Cap:609.59K
PE:- -
High:30.48
Open:30.46
Low:30.46
Close:30.46
52wk High:30.68
52wk Low:24.78
Shares:20.00K
Float Shares:20.00K
Volume Ratio:0.50
T/O Rate:2.62%
Dividend:0.09
Dividend Rate:0.28%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Merck & Co Inc : RBC Cuts to Sector Perform from Outperform; Raises Target Price to $150 from $142

THOMSON REUTERS
·
Aug 20

Morgan Stanley Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $179 From $116

MT Newswires Live
·
Aug 20

China, Hong Kong Stocks Rise on Healthcare, Tech Advance

Reuters
·
Aug 20

Health Care Roundup: Market Talk

Dow Jones
·
Aug 20

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Reuters
·
Aug 20

Guotai Asset Management Sees Liquidity Boost Driving China Biotech, Innovation Drug Shares Higher

Reuters
·
Aug 20

7 Growth Stocks Holding up in a Tough Market

Dow Jones
·
Aug 20

Gubra H1 FY26 Operating Loss Widens to DKK 122.9 Million; Revenue Drops 95% to DKK 126.3 Million

Reuters
·
Aug 20

Merck & Co Inc : Jefferies Raises Target Price to $175 from $152

THOMSON REUTERS
·
Aug 20

Will Foundayo’s UK GLP‑1 Approval and New R&D Deals Change Eli Lilly's (LLY) Narrative?

Simply Wall St.
·
Aug 20

Today’s Market Recap:U.S. Treasury Steps In to Stabilize Markets,Stocks Rally, Bitcoin Breaks $70,000, Moderna Surges 180%

TradingKey
·
Aug 20

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 20

Zoetis Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 20

Merck & Co. Inc. Stock Advances 12.6%, Outperforms Peers

Dow Jones
·
Aug 20

Merck upgraded to Overweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Aug 20

Moderna's Cancer-Vaccine Breakthrough Drives Broad Biopharma Stock Rally

Dow Jones
·
Aug 20

Moderna Shares More than Double on Success of mRNA Cancer Vaccine

Dow Jones
·
Aug 20

Amplitude Therapeutics: Lilly to GET Exclusive, Target-Specific Rights to Develop ,Commercialize Licensed Products Directed to Collaboration Targets

THOMSON REUTERS
·
Aug 20

Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying Rna Vaccines for Infectious Diseases

THOMSON REUTERS
·
Aug 20

Amplitude: Initial Programs Target Infectious Diseases with High Unmet Need, with Lilly Retaining Options for up to Two Additional Targets

THOMSON REUTERS
·
Aug 20